ESTA Files Routine 8-K: Administrative Update, No New News
Ticker: ESTA · Form: 8-K · Filed: Jan 31, 2024 · CIK: 1688757
| Field | Detail |
|---|---|
| Company | Establishment Labs Holdings Inc. (ESTA) |
| Form Type | 8-K |
| Filed Date | Jan 31, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: administrative, compliance, 8-K
TL;DR
**ESTA's 8-K is just a compliance update, nothing new for traders.**
AI Summary
Establishment Labs Holdings Inc. filed an 8-K on January 31, 2024, to report "Other Events" and "Financial Statements and Exhibits." This filing primarily updates administrative information, confirming the company's registration with the SEC under the 1934 Act, its British Virgin Islands incorporation, and its common shares trading on The NASDAQ Capital Market under the symbol ESTA. For investors, this filing is routine and indicates ongoing compliance, but it doesn't reveal new financial performance or strategic changes that would immediately impact the stock price.
Why It Matters
This filing is a standard administrative update, confirming Establishment Labs' compliance with SEC reporting requirements. It doesn't contain new financial or operational information that would typically move the stock.
Risk Assessment
Risk Level: low — This 8-K is a routine administrative filing and does not introduce new financial or operational risks.
Analyst Insight
A smart investor would recognize this as a standard compliance filing with no new material information. It's not a trigger for buying or selling, but rather a confirmation of ongoing regulatory adherence.
Key Numbers
- 001-38593 — Commission File No. (identifies Establishment Labs Holdings Inc.'s registration with the SEC)
- 98-1436377 — I.R.S. Employer Identification Number (identifies Establishment Labs Holdings Inc. for tax purposes)
- January 31, 2024 — Date of Report (the date of the earliest event reported in the 8-K filing)
- +506 2434 2400 — Registrant’s telephone number (contact information for Establishment Labs Holdings Inc.)
Key Players & Entities
- Establishment Labs Holdings Inc. (company) — the registrant filing the 8-K
- British Virgin Islands (company) — state of incorporation for Establishment Labs Holdings Inc.
- The NASDAQ Capital Market (company) — exchange where Establishment Labs Holdings Inc.'s common shares are registered
- ESTA (company) — trading symbol for Establishment Labs Holdings Inc.
FAQ
What is the purpose of this 8-K filing by Establishment Labs Holdings Inc.?
This 8-K filing, dated January 31, 2024, is categorized under "Other Events" and "Financial Statements and Exhibits." It primarily serves as a routine administrative update, confirming the company's registration details and compliance with the Securities Exchange Act of 1934.
Where is Establishment Labs Holdings Inc. incorporated and where are its principal executive offices located?
Establishment Labs Holdings Inc. is incorporated in the British Virgin Islands. Its principal executive offices are located at Building B15 and 25 Coyol Free Zone, Alajuela, Costa Rica.
What is the trading symbol and the exchange where Establishment Labs Holdings Inc.'s shares are registered?
The trading symbol for Establishment Labs Holdings Inc.'s common shares is ESTA, and they are registered on The NASDAQ Capital Market.
Does this 8-K filing indicate that Establishment Labs Holdings Inc. is an emerging growth company?
The filing includes a checkbox section to indicate if the registrant is an emerging growth company, but none of the boxes are checked, implying the company is not currently identifying itself as an emerging growth company under Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Exchange Act.
What specific items are reported in this 8-K filing?
The filing specifically reports under "ITEM INFORMATION: Other Events" and "ITEM INFORMATION: Financial Statements and Exhibits." However, the content provided in the extract is largely administrative and does not detail specific new events or exhibits beyond the company's basic registration information.
Filing Stats: 564 words · 2 min read · ~2 pages · Grade level 10.8 · Accepted 2024-01-31 16:35:10
Filing Documents
- esta-20240131.htm (8-K) — 30KB
- ex5113124.htm (EX-5.1) — 15KB
- image_0.jpg (GRAPHIC) — 16KB
- image_1.jpg (GRAPHIC) — 54KB
- 0001688757-24-000011.txt ( ) — 271KB
- esta-20240131.xsd (EX-101.SCH) — 2KB
- esta-20240131_lab.xml (EX-101.LAB) — 24KB
- esta-20240131_pre.xml (EX-101.PRE) — 13KB
- esta-20240131_htm.xml (XML) — 3KB
01. Other Events
Item 8.01. Other Events. On January 31, 2024, Establishment Labs Holdings Inc. (the "Company") filed with the U.S. Securities and Exchange Commission (the "SEC") a prospectus supplement (the "Prospectus Supplement") to its prospectus dated April 24, 2023, which was included in the registration statement on Form S-3 (Registration No. 333-271418) filed with the SEC on April 24, 2023. The Prospectus Supplement relates to the offering and sale from time to time of up to 2,000,000 of the Company's common shares, no par value per share (the "Common Shares") by the selling shareholders identified in the Prospectus Supplement consisting of (a) 1,101,565 Common Shares and (b) 898,435 Common Shares issuable upon the exercise of pre-funded warrants held by certain of the selling shareholders in connection with the Company's previously disclosed securities purchase agreement dated as of January 9, 2024. An opinion of the Company's counsel, Conyers Dill & Pearman, regarding the legality of the Common Shares covered by the Prospectus Supplement described above is filed as Exhibit 5.1 hereto.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 5.1 Opinion of Conyers Dill & Pearman 23.1 Consent of Conyers Dill & Pearman (included in Exhibit 5.1) 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. ESTABLISHMENT LABS HOLDINGS INC. Dated: January 31, 2024 By: /s/ Rajbir S. Denhoy Name: Rajbir S. Denhoy Title: Chief Financial Officer